[Use of the preparation Essenciale in chronic ischemic heart disease]. 1978

V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova

The efficacy of the drug "essentiale" is discussed on the basis of observation over 34 patients suffering from ischemic heart disease with functional hepatic insufficiency and types IIa and IIb hyperlipoproteinemia. Its normalizing effect on the indices of lipid metabolism the flow of blood in the leg and foot, the vascular tone, and liver function is shwon.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
November 1984, Vrachebnoe delo,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
October 1979, Kardiologiia,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
March 1979, Voenno-meditsinskii zhurnal,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
June 1991, American heart journal,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
March 1981, Vrachebnoe delo,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
September 1989, Vrachebnoe delo,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
April 2000, American heart journal,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
August 1986, Vrachebnoe delo,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
January 1977, Terapevticheskii arkhiv,
V G Kukes, and E A Senik, and E T Gneushev, and S A Potekaeva, and N M Milovanova
January 1988, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
Copied contents to your clipboard!